Agena Bioscience® in the News

Recent Press Releases

  • Agena Announces MassARRAY® Technology Selected for Participation in CANCER-ID Consortium More

    San Diego, CA, July 24, 2018 – Agena Bioscience, a global provider of molecular testing solutions, announced today that it has been selected for participation

  • Agena and DaRui Biotechnology Announce China FDA Clearance of MassARRAY® Technology for Diagnostic Use in China More

    San Diego, CA and Guangzhou, China, Wednesdy, October 24, 2018 - Agena Bioscience (Agena) and DaRui Biotechnolog (DaRui) announced today that the MassARRAY®

  • Agena Bioscience Announces Collaboration with PerkinElmer More

    Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena

  • Agena Announces MassARRAY® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market More

    San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement with Zhejiang Dian Diagnostics

  • GenomeWeb 360Dx: Agena Looks to China for Global Expansion of the MassARRAY Platform More

    New York, NY (360DX), June 6, 2018 –  For Agena Bioscience CEO Peter Dansky, expanding a diagnostics company means going where the growth is, and for

  • Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China More

    San Diego, CA, and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical